{
  "ticker": "LH",
  "last_updated": "2025-04-19T06:40:54.085766",
  "retention_years": 3,
  "count": 43,
  "transactions": [
    {
      "id": 1786,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-21",
      "transaction_shares": "500",
      "transaction_price": "215.4901",
      "transaction_type": "S",
      "shares_after_transaction": "3400.5491"
    },
    {
      "id": 1788,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-21",
      "transaction_shares": "14054",
      "transaction_price": "163.63",
      "transaction_type": "M",
      "shares_after_transaction": "58099"
    },
    {
      "id": 1773,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-13",
      "transaction_shares": "237",
      "transaction_price": "226.45",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 1780,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-11",
      "transaction_shares": "807",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "44260"
    },
    {
      "id": 1782,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8091.1426"
    },
    {
      "id": 1787,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "472",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21523.0428"
    },
    {
      "id": 1801,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "123",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2384.2194"
    },
    {
      "id": 1802,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4152"
    },
    {
      "id": 1803,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "2964",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "54225"
    },
    {
      "id": 1809,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23703"
    },
    {
      "id": 1812,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-11",
      "transaction_shares": "201",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3959.5491"
    },
    {
      "id": 1813,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-11",
      "transaction_shares": "324",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7960.979"
    },
    {
      "id": 1805,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-08",
      "transaction_shares": "259",
      "transaction_price": "222.06",
      "transaction_type": "S",
      "shares_after_transaction": "7636.979"
    },
    {
      "id": 1770,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23473"
    },
    {
      "id": 1771,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Davis Jeffrey A.",
      "reporting_owner_cik": "0001648477",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3619"
    },
    {
      "id": 1772,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Parham Richelle P",
      "reporting_owner_cik": "0001550078",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8534"
    },
    {
      "id": 1776,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "ANDERSON KERRII B",
      "reporting_owner_cik": "0001227159",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16222"
    },
    {
      "id": 1777,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21143.0428"
    },
    {
      "id": 1778,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-07",
      "transaction_shares": "885",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43689"
    },
    {
      "id": 1779,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "517",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7638.1426"
    },
    {
      "id": 1783,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "134",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2307.2194"
    },
    {
      "id": 1785,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3739.5491"
    },
    {
      "id": 1789,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "4024"
    },
    {
      "id": 1790,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wengel Kathryn E",
      "reporting_owner_cik": "0001745955",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2292"
    },
    {
      "id": 1792,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "353",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7989.979"
    },
    {
      "id": 1794,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BELINGARD JEAN-LUC",
      "reporting_owner_cik": "0001200845",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "17876"
    },
    {
      "id": 1796,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "GRAHAM ANITA Z",
      "reporting_owner_cik": "0001206814",
      "reporting_owner_position": "EVP, CHRO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "369",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "399"
    },
    {
      "id": 1798,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Gilliland Dwight Gary",
      "reporting_owner_cik": "0001603769",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8712"
    },
    {
      "id": 1799,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-07",
      "transaction_shares": "3250",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "52410"
    },
    {
      "id": 1800,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "NEUPERT PETER M",
      "reporting_owner_cik": "0001237566",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11943"
    },
    {
      "id": 1804,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Williams R Sanders",
      "reporting_owner_cik": "0001375347",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8120"
    },
    {
      "id": 1807,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kong Garheng",
      "reporting_owner_cik": "0001435183",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "11898"
    },
    {
      "id": 1808,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Bailey Megan D.",
      "reporting_owner_cik": "0001975682",
      "reporting_owner_position": "EVP, Chief Strategy Officer",
      "transaction_date": "2024-02-07",
      "transaction_shares": "224",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "346"
    },
    {
      "id": 1810,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kliphouse Kirsten Marie",
      "reporting_owner_cik": "0001948684",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-07",
      "transaction_shares": "947",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "1319"
    },
    {
      "id": 1774,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, Pres of ED, CMO & CSO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "20792.0428"
    },
    {
      "id": 1775,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "131",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "2218.2194"
    },
    {
      "id": 1781,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2024-02-02",
      "transaction_shares": "856",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "43032"
    },
    {
      "id": 1784,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "DiVincenzo Jonathan P.",
      "reporting_owner_cik": "0001453524",
      "reporting_owner_position": "EVP, Pres, Central Labs & Intl",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3600.5491"
    },
    {
      "id": 1791,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "3094",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "49982"
    },
    {
      "id": 1793,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "van der Vaart Sandra D",
      "reporting_owner_cik": "0001537208",
      "reporting_owner_position": "EVP, Chief Legal Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "264",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7900.979"
    },
    {
      "id": 1795,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Summy Amy B.",
      "reporting_owner_cik": "0001805303",
      "reporting_owner_position": "EVP, Chief Marketing Officer",
      "transaction_date": "2024-02-02",
      "transaction_shares": "246",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "3880"
    },
    {
      "id": 1797,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "BERBERIAN LANCE",
      "reporting_owner_cik": "0001102900",
      "reporting_owner_position": "EVP, CIO & CTO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "331",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "23209"
    },
    {
      "id": 1806,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, Pres Diagnostics & COO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "495",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7253.1426"
    }
  ]
}